Candel Therapeutics, Inc. (CADL) earnings per share (EPS)

Earnings per share · fiscal 2025
-$0.72

Candel Therapeutics, Inc. (CADL) reported diluted earnings per share of -$0.72 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.74. Figures as of 18 Nov 2026, 12:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$0.72
Highest on record
-$0.65fiscal 2022
Lowest on record
-$1.91fiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Candel Therapeutics, Inc. earnings per share (EPS), in more detail

Across the 5 fiscal years on record (2021–2025), the highest was -$0.65 in fiscal 2022 and the lowest -$1.91 in fiscal 2021.

History · 5 fiscal years

Earnings per share by fiscal year

Candel Therapeutics, Inc. earnings per share (EPS), year by year

Candel Therapeutics, Inc. (CADL) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$0.72—
2024-$1.74—
2023-$1.31—
2022-$0.65—
2021-$1.91—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on CADL

Candel Therapeutics, Inc., figure by figure

Candel Therapeutics, Inc. (CADL) overview: price, valuation and scorecard

Candel Therapeutics, Inc. earnings per share (EPS): questions and answers

What is Candel Therapeutics, Inc.'s diluted earnings per share?

Candel Therapeutics, Inc. (CADL) reported diluted earnings per share of -$0.72 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.74.

What are the highest and lowest diluted earnings per share figures on record for Candel Therapeutics, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was -$0.65 in fiscal 2022 and the lowest -$1.91 in fiscal 2021.

How is Candel Therapeutics, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits. For Candel Therapeutics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Candel Therapeutics, Inc. (CADL) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/CADL/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.